Acura Pharmaceuticals Inc banner

Intrinsic Value

ACUR doesn't have a meaningful market cap.
Not Available for ACUR

There is not enough data to reliably calculate the intrinsic value for Acura Pharmaceuticals Inc.

Do our valuations actually work? See backtest results .

Alternatives to ACUR

Fundamental Analysis

What Acura Pharmaceuticals Does

Pharmaceuticals Health Care

Acura Pharmaceuticals, Inc. is a drug delivery company, which engages in the research, development, and commercialization of technologies and products intended to address safe use of medications. The company is headquartered in Palatine, Illinois. The company went IPO on 2000-09-12. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested.

Headquarters
United States of America US
IPO date
Sep 12, 2000
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Acura Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

ACUR Insider Trading
Buy and sell transactions by insiders